Lv72
3790 积分 2020-10-26 加入
Long-term prognosis of lean MASLD: evidence from three population-based prospective cohorts
1个月前
已完结
Non-alcoholic fatty liver disease in non-obese individuals: the impact of metabolic health
1个月前
已完结
Association of frailty and pre-frailty with all-cause and cardiovascular mortality in diabetes: three prospective cohorts and a meta-analysis
4个月前
已完结
Management of frailty: opportunities, challenges, and future directions
4个月前
已完结
Prehabilitation-Driven Changes in Frailty Metrics Predict Mortality in Patients With Advanced Liver Disease
4个月前
已完结
Fatty liver disease along Cushing’s syndrome evolution
6个月前
已完结
Revisiting gender differences in obesity and type 2 diabetes: Letter to the editor
6个月前
已完结
Precision nutrition in aging: enhancing frailty prevention through personalized dietary interventions
6个月前
已完结
Efficacy and safety of once-weekly tirzepatide in Japanese patients with obesity disease (SURMOUNT-J): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
7个月前
已完结
Access to GLP-1 Weight Loss Drugs in the US, Canada, Switzerland, and Germany
8个月前
已完结
皖公网安备34019202002308
